Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Kerry Gairy's publication output changed over time?
ScholarIQpublication output · 2009–2023
Output grew100% over the shown period — from 1 works in 2009 to 2 in 2023.
1
1
1
1
1
2
2
1
2
200920102011201220142020202120222023
What are the most-cited papers on Kerry Gairy?
ScholarIQmost cited works
Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression
Anadi Mahajan, Justyna Amelio, Kerry Gairy, Gavneet Kaur, Roger A. Levy, David A. Roth, Damon Bass
Lupus. 2020208 CitationsOPEN ACCESS
10 Years of belimumab experience: What have we learnt?
Roger A. Levy, Tania Gonzalez‐Rivera, Munther A. Khamashta, Norma Lynn Fox, Angela R. Jones-Leone, Bernie Rubin, Susan W. Burriss, Kerry Gairy, André van Maurik, David A. Roth
Lupus. 2021130 CitationsOPEN ACCESS
A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence
Susan D. Ross, E. R. Samuels, Kerry Gairy, Sheikh Usman Iqbal, Enkhe Badamgarav, Ethel S. Siris
Value in Health. 2011113 CitationsOPEN ACCESS
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial
Paul Mitchell, Lieven Annemans, Meghan Gallagher, Rafiq Hasan, Simu K. Thomas, Kerry Gairy, M.S. Knudsen, Henrietta Onwordi
British Journal of Ophthalmology. 201282 CitationsOPEN ACCESS
Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review
Julie Glanville, Jacoby Patterson, Rachael McCool, Alberto Ferreira, Kerry Gairy, Ian Pearce
BMC Ophthalmology. 201461 CitationsOPEN ACCESS
Related on ScholarIQ
Health Economics and Outcomes Research (United Kingdom)
Institution
Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression
Paper
10 Years of belimumab experience: What have we learnt?
Paper
A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence
Paper
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial
Paper
Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review
Paper